<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00329615</url>
  </required_header>
  <id_info>
    <org_study_id>kl450112</org_study_id>
    <nct_id>NCT00329615</nct_id>
  </id_info>
  <brief_title>Insulin Treatment in Cancer Cachexia</brief_title>
  <official_title>Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Cancer Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <brief_summary>
    <textblock>
      The study is designed to evaluate whether daily insulin treatment to weight losing cancer
      patients attenuates progression of cancer cachexia and improves metabolism.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized study with long-term follow-up based on survival, health related quality of life,
      food intake, resting energy expenditure, body composition, exercise capacity and measurement
      of metabolic efficiency.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Actual">September 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health related quality of life,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>food intake,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>resting energy expenditure,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>body composition,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>metabolic efficiency,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>spontaneous physical activity,</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>blood and hormonal tests</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>serum tumor markers</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
  </secondary_outcome>
  <enrollment>135</enrollment>
  <condition>Cancer Cachexia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulatard, flexpen</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Weight loss

          -  Systemic solid cancer

        Exclusion Criteria:

          -  Diabetes

          -  Brain metastases

          -  Expectant survival of less than 6 months

          -  Serum creatinine above 200 umol/l

          -  Persistent of recurrent fever

          -  Cholestasis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kent G Lundholm, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgery, Göteborg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery, Inst of Clinical Sciences</name>
      <address>
        <city>Göteborg</city>
        <zip>SE413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2006</study_first_submitted>
  <study_first_submitted_qc>May 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2006</study_first_posted>
  <last_update_submitted>August 20, 2009</last_update_submitted>
  <last_update_submitted_qc>August 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2009</last_update_posted>
  <keyword>Cancer cachexia</keyword>
  <keyword>Tumor host metabolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cachexia</mesh_term>
    <mesh_term>Wasting Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Isophane Insulin, Human</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

